338 related articles for article (PubMed ID: 17981087)
1. Right on target: eradicating leukemic stem cells.
Krause DS; Van Etten RA
Trends Mol Med; 2007 Nov; 13(11):470-81. PubMed ID: 17981087
[TBL] [Abstract][Full Text] [Related]
2. Considerations for targeting malignant stem cells in leukemia.
Guzman ML; Jordan CT
Cancer Control; 2004; 11(2):97-104. PubMed ID: 15024346
[TBL] [Abstract][Full Text] [Related]
3. Targeting myeloid leukemia stem cells.
Jordan CT
Sci Transl Med; 2010 May; 2(31):31ps21. PubMed ID: 20463365
[TBL] [Abstract][Full Text] [Related]
4. TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells.
Kikushige Y; Miyamoto T
Int J Hematol; 2013 Dec; 98(6):627-33. PubMed ID: 24046178
[TBL] [Abstract][Full Text] [Related]
5. Concise Review: Exploiting Unique Biological Features of Leukemia Stem Cells for Therapeutic Benefit.
Zhang H; Li S
Stem Cells Transl Med; 2019 Aug; 8(8):768-774. PubMed ID: 31016860
[TBL] [Abstract][Full Text] [Related]
6. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities.
Marchand T; Pinho S
Front Immunol; 2021; 12():775128. PubMed ID: 34721441
[TBL] [Abstract][Full Text] [Related]
7. Targeting the leukemic stem cell: the Holy Grail of leukemia therapy.
Misaghian N; Ligresti G; Steelman LS; Bertrand FE; Bäsecke J; Libra M; Nicoletti F; Stivala F; Milella M; Tafuri A; Cervello M; Martelli AM; McCubrey JA
Leukemia; 2009 Jan; 23(1):25-42. PubMed ID: 18800146
[TBL] [Abstract][Full Text] [Related]
8. Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncology.
ten Cate B; de Bruyn M; Wei Y; Bremer E; Helfrich W
Curr Drug Targets; 2010 Jan; 11(1):95-110. PubMed ID: 20017722
[TBL] [Abstract][Full Text] [Related]
9. Recent progress on targeting leukemia stem cells.
Ma XY; Wei L; Lei Z; Chen Y; Ding Z; Chen ZS
Drug Discov Today; 2021 Aug; 26(8):1904-1913. PubMed ID: 34029689
[TBL] [Abstract][Full Text] [Related]
10. [Molecular targeted therapy for leukemic stem cells].
Kikushige Y
Nihon Rinsho; 2015 May; 73(5):811-5. PubMed ID: 25985636
[TBL] [Abstract][Full Text] [Related]
11. Expression of putative leukemia stem cell targets in genetically-defined acute myeloid leukemia subtypes.
Yanagisawa B; Perkins B; Karantanos T; Levis M; Ghiaur G; Smith BD; Jones RJ
Leuk Res; 2020 Dec; 99():106477. PubMed ID: 33220589
[TBL] [Abstract][Full Text] [Related]
12. Acute myelogenous leukemia stem cells: from Bench to Bedside.
Felipe Rico J; Hassane DC; Guzman ML
Cancer Lett; 2013 Sep; 338(1):4-9. PubMed ID: 22713929
[TBL] [Abstract][Full Text] [Related]
13. TIM-3 as a therapeutic target for malignant stem cells in acute myelogenous leukemia.
Kikushige Y; Akashi K
Ann N Y Acad Sci; 2012 Aug; 1266():118-23. PubMed ID: 22901263
[TBL] [Abstract][Full Text] [Related]
14. [New approaches to target leukemia stem cells].
Takenaka K; Akashi K
Nihon Rinsho; 2014 Jun; 72(6):1018-25. PubMed ID: 25016798
[TBL] [Abstract][Full Text] [Related]
15. Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia.
Laing AA; Harrison CJ; Gibson BES; Keeshan K
Exp Hematol; 2017 Oct; 54():40-50. PubMed ID: 28668350
[TBL] [Abstract][Full Text] [Related]
16. Could Vitamin D Analogues Be Used to Target Leukemia Stem Cells?
García-Ramírez I; Martín-Lorenzo A; González-Herrero I; Rodriguez-Hernández G; Vicente-Dueñas C; Sánchez-García I
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27275819
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells.
Jin L; Lee EM; Ramshaw HS; Busfield SJ; Peoppl AG; Wilkinson L; Guthridge MA; Thomas D; Barry EF; Boyd A; Gearing DP; Vairo G; Lopez AF; Dick JE; Lock RB
Cell Stem Cell; 2009 Jul; 5(1):31-42. PubMed ID: 19570512
[TBL] [Abstract][Full Text] [Related]
18. Expression of multiple leukemic stem cell markers is associated with poor prognosis in de novo acute myeloid leukemia.
Yabushita T; Satake H; Maruoka H; Morita M; Katoh D; Shimomura Y; Yoshioka S; Morimoto T; Ishikawa T
Leuk Lymphoma; 2018 Sep; 59(9):2144-2151. PubMed ID: 29251166
[TBL] [Abstract][Full Text] [Related]
19. Targeting LSCs through membrane antigens selectively or preferentially expressed on these cells.
Pelosi E; Castelli G; Testa U
Blood Cells Mol Dis; 2015 Dec; 55(4):336-46. PubMed ID: 26460257
[TBL] [Abstract][Full Text] [Related]
20. The variety of leukemic stem cells in myeloid malignancy.
Wiseman DH; Greystoke BF; Somervaille TC
Oncogene; 2014 Jun; 33(24):3091-8. PubMed ID: 23831573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]